MindMaze Therapeutics Holding SA

MindMaze Therapeutics operates with a cash and equivalents position of CHF 9.47 million, and a total equity of CHF 38.34 million, indicating a strong liquidity position with no long-term debt. The company's current ratio of 1.2 suggests it has sufficient current assets to cover its current liabilities, though it is not significantly overfunded. The company reported a net loss of CHF 9.91 million and an operating loss of CHF 10.52 million, with a return on equity of -25.84% and a return on assets of -19.22%, which are significantly below the industry median for profitability and returns. These figures indicate that the company is not generating returns on its equity or assets and is underperforming in terms of profitability. MindMaze Therapeutics' revenue is concentrated in a single business segment, with no disclosed geographic breakdown, suggesting a lack of diversification in its revenue streams. The company's revenue of CHF 642,000 is below the mean analyst estimate of CHF 5.5 million, indicating a potential underperformance in revenue generation. The company's growth trajectory is negative, with a net loss and operating loss increasing from previous periods. The mean analyst estimate for EBIT is CHF -12.17 million, which is in line with the company's reported operating loss, suggesting a continuation of the current trend. The company's capital expenditures of CHF -6.24 million indicate ongoing investment, but the negative free cash flow of CHF -14.51 million suggests that these investments are not yet generating positive cash returns. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's dilution potential is low, and no adjustments have been applied to the valuation metrics, suggesting that the company is not currently at risk of significant equity dilution. Recent events include a significant ESG controversies score of 100.0, indicating high controversy in ESG practices, and a governance pillar score of 30.4, which is low, suggesting potential governance concerns. The company's ESG social pillar score of 49.9 is moderate, indicating some level of social responsibility but with room for improvement.